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The role of WNT signaling and its interactions with other morphogenetic pathways were investigated during lung development. Previously, we
showed that targeted disruption of Wnt5a results in over-branching of the epithelium and thickening of the interstitium in embryonic lungs. In this
study, we generated and characterized transgenic mice with lung-specific over-expression of Wnt5a from the SpC promoter. Over-expression of
Wnt5a interfered with normal epithelial–mesenchymal interactions resulting in reduced epithelial branching and dilated distal airways. During
early lung development, over-expression of Wnt5a in the epithelium resulted in increased Fgf10 in the mesenchyme and decreased Shh in the
epithelium. Both levels and distribution of SHH receptor, Ptc were reduced in SpC-Wnt5a transgenic lungs and were reciprocally correlated to
changes of Fgf10 in the mesenchyme, suggesting that SHH signaling is decreased by over-expression of Wnt5a. Cultured mesenchyme-free
epithelial explants from SpC-Wnt5a transgenic lungs responded abnormally to recombinant FGF10 supplied uniformly in the Matrigel with dilated
branch tips that mimic the in vivo phenotype. In contrast, chemotaxis of transgenic epithelial explants towards a directional FGF10 source was
inhibited. These suggest that over-expression of Wnt5a disrupts epithelial-response to FGF10. In conclusion, Wnt5a regulates SHH and FGF10
signaling during lung development.
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The lungs are an endodermally derived organ whose
formation requires branching morphogenesis, a process that
is dependent on cell-to-cell communications between the
endodermally derived lung epithelium and the splanchnic
mesenchyme. Epithelial–mesenchymal interactions in the
lung, as in other tissues, are mediated through the activities
of a complex network of molecules localized in the epithelium
or the mesenchyme or both with distinct patterns of expression
(reviewed by Cardoso, 2000). These molecules can be grouped
into three broad functional categories: (1) signaling molecules
that include peptide growth factors (e.g., FGF, PDGF, EGF,
TGF-beta), morphogens (e.g., Retinoic acid) as well as0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.08.035
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E-mail address: changgon@usc.edu (C. Li).morphogen-like molecules (e.g., SHH, and WNTs), (2)
transcription factors (e.g., NKX2.1, Forkhead family members,
GATA) and (3) extracellular matrix proteins and their receptors
(e.g., laminin, fibronectin and alpha-integrins).
Although many of the mediators, such as those mentioned
above are beginning to be identified, their interactions remain
poorly understood. Much of what is currently known about
the role of individual mediators of lung morphogenesis has
come from the analysis of the phenotypes resulting from
either targeted disruption, or ectopic transgenic over-expres-
sion of the genes involved. For example, the most profound
interruption in lung morphogenesis is observed in Fgf10 null
embryos where the lungs lack structures distal to mainstem
bronchi (Min et al., 1998). FGF10 is produced by lung
mesenchymal cells and acts as a chemotactic factor on the
adjacent epithelium. In the epithelium, a central signaling
pathway appears to be SHH. The role of Shh during lung
development has also been demonstrated by both gene-287 (2005) 86 – 97
www.e
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celli et al., 1998; Bellusci et al., 1997a; Miller et al., 2004).
Deletion of Shh in the lung causes failure of branching and
growth of the distal lung (Pepicelli et al., 1998; Miller et al.,
2004). SHH signal from the epithelium negatively regulates
Fgf10 (Lebeche et al., 1999) and may spatially restrict its
expression within the distal mesenchyme (Pepicelli et al.,
1998). Although the major site of Bmp4 expression in the
developing lung is the epithelium, low level expression can
also be detected in the mesenchymal cells. Bmp4 is localized to
the distal-most tips of the developing airways where it is
thought to be critical for normal branching morphogenesis.
More broad- and over-expression of Bmp4 in transgenic mice
using the promoter of the lung-specific gene Surfactant Protein
C, SpC, results in less extensive branching with fewer, grossly
dilated terminal buds (Bellusci et al., 1996). FGF10 stimulates
Bmp4 gene expression in the near-by epithelium (Lebeche et
al., 1999).
The functional role of WNT proteins in organogenesis,
particularly that of the lung has been recently addressed (Li et
al., 2002a; Shu et al., 2002; Mucenski et al., 2003; De
Langhe et al., 2005). WNTs are cysteine-rich secreted
glycoproteins that are vertebrate homologues of Drosophila
wingless. Members of Wnt family have distinct expression
patterns in the embryo and adult organisms and are critical
for regulation of tissue differentiation and organogenesis (For
a detailed easily accessed review, please see the Wnt
Homepage at: www.stanford.edu/¨rnusse/wntwindow.html).
Binding of WNT ligands to their receptors, known as
Frizzled (Fzd) and LDL-receptor-related proteins (LRP) -5
or -6, results in activation of at least three intracellular
pathways that are reported to mediate WNT signaling
(reviewed by Miller et al., 1999; Huelsken and Birchmeier,
2001). The ‘‘canonical’’ Wnt/beta-catenin pathway is primar-
ily related to cell fate determination and is mediated through
stabilization of beta-catenin and activation of the Lymphoid
enhancer-binding factor/T-cell factor (Lef/Tcf) through which
target gene expression is regulated. The ‘‘non-canonical’’,
beta-catenin-independent pathways are Wnt/Ca2+ and Wnt/
polarity pathways which mediated signaling through activa-
tion of Protein Kinase C (PKC) (Kuhl et al., 2001; Mudher et
al., 2001) and c-jun N-terminal kinase (JNK), respectively
(Yamanaka et al., 2002). Wnt5a represents a functional
subclass of Wnt family members, including Wnt5a, Wnt11
and Wnt4, which lack transforming activity in mammary
C57MG cells (reviewed by Wodarz and Nusse, 1998).
Members of the WNT5A subclass can signal via the non-
canonical pathways, but their role on the canonical pathway
remains unclear.
Function of the canonical pathway mediator, beta-catenin,
in lung development was determined by conditional gene
targeting approaches (Mucenski et al., 2003). When beta-
catenin was deleted from embryonic lung epithelial cells,
formation and differentiation of the peripheral lung was
restricted, and formation of the conducting airways was
enhanced. Also, over-expression of a constitutively active
beta-catenin–Lef1 fusion protein in developing lung switchedlineage commitment and resulted in generation of intestine-like
cell types (Okubo and Hogan, 2003). In the lung, the role of
two members of the Wnt family, Wnt5a and Wnt7b, have been
investigated using gene-targeting approaches. Shu et al. (2002)
showed that Wnt7b signaling is required for proper lung
mesenchymal growth and vascular development. We previous-
ly reported that lungs of Wnt5a(/) mice exhibit over-
branching of the epithelial airway and thickening of the
mesenchymal interstitium suggesting that Wnt5a regulates
epithelial–mesenchymal interactions in the developing lung
(Li et al., 2002a).
In the current study, we generated transgenic mice that over-
express Wnt5a in the developing lung epithelium. The results
demonstrate that epithelial–mesenchymal interaction in Wnt5a
transgenic lungs is disrupted, manifested as malformations in
both the epithelial airway and the surrounding mesenchyme.
The epithelial airways exhibit reduced branching and dilated
distal tips and the surrounding mesenchyme are overgrown. In
correspondence to the abnormal development of epithelium
and mesenchyme, expression and distribution of key signaling
factors such as Shh, Ptc, Fgf10 and Bmp4 are changed in
Wnt5a transgenic lungs.
Results
Generation of SpC-Wnt5a transgenic mice
Seven SpC-Wnt5a transgenic mouse lines were generated
and genotyped by Southern blot analysis (lanes 2, 3, 4, 6, 12,
13 and 16, Fig. 1A). All seven founders were born alive and
were viable postnatally. The founders were crossed to wild-
type C57BL/6 to generate F1 transgenic males. Wild-type
C57BL/6 females were then crossed with the F1 transgenic
males to obtain F2 progeny that were used in this study. The
two transgenic lines, #3 and #13, that had the highest copy
number of transgene were analyzed and found to represent the
same overall lung phenotype. In this manuscript, we report the
results obtained from the analysis of the transgenic line #13.
Northern blot analysis was used to quantify the expression
level of Wnt5a transgene mRNA in lungs of postnatal day 20
(PN20) mice (Fig. 1B). Because Wnt5a transgene mRNA is
around 2.7 kb and includes 200 nucleotides of SV40
sequences, a 0.4-kb SV40-t-intron-polyA sequence was used
as probe in the Northern blot analyses. High levels of Wnt5a
transgene mRNA were detected in the transgenic lungs and as
expected no transcripts were detected in non-transgenic
controls (Fig. 1B).
Distribution of WNT5A protein in control and transgenic
lungs was determined by immunohistochemistry with a
WNT5A antibody (R and D systems). Previously, we
determined that in E16 lungs, WNT5A protein is localized
primarily to the distal epithelium with low-level expression in
the mesenchyme (Li et al., 2002a). A similar pattern of
distribution of endogenous WNT5Awas observed in E13 wild-
type lungs (Fig. 1C). The level of WNT5A in transgenic lungs
was significantly increased in the distal airway epithelium (Fig.
1D). This pattern correlates with the reported pattern of SpC
Fig. 1. Generating Wnt5a transgenic mice. Panel A, genotyping of transgenic founders by Southern blot. Genomic DNA from the mouse tails was digested with
Kpn1, resolved by gel electrophoresis and Southern blotted. The blots were hybridized using a 32P labeled probe derived from a 2.5-kb EcoRI fragment of Wnt5a
cDNA. The Kpn1 fragment of the transgenic construct is about 3.5 kb in size. Numbers indicate the numbering of F0 pups. C contains 15 pg of Kpn1 fragment of the
SpC-Wnt5a construct, which contains 0.5 kb of SpC promoter and 2.5 kb of Wnt5a sequences. Panel B, Northern blot of RNA from postnatal day 20 wild type (C)
and transgenic (T) lungs using aWnt5a transgene-specific probe derived from the SV40 t-intron-poly A sequence. TransgenicWnt5a transcripts, about 2.7 kb in size,
are abundant in the transgenic lungs (T). Equal amount of RNAwas loaded based on the amount of 18s rRNA. Panels C and D, immunohistostaining of WNT5A in
E13 wild type (C) and transgenic (D) lungs. Arrows indicate the distal airways and arrowheads indicate the proximal airways. Scale bar, 200 Am (C, D).
C. Li et al. / Developmental Biology 287 (2005) 86–9788promoter activity (Wert et al., 1993) and overlaps with sites of
endogenous WNT5A. To prevent potential alteration of native
structure and function of the transgenic protein, a tag was not
included in construction of the SpC-Wnt5a vector. Therefore,
the WNT5A protein detected in transgenic lungs includes both
endogenous and transgenic molecules.
Reduced branching, dilated airways and abnormal lobation in
Wnt5a transgenic lungs
To examine the impact of Wnt5a over-expression on lung
development, the phenotype of lungs obtained from E12, E14
and E19 embryos were systematically characterized. Wnt5a
transgenic lungs at all stages analyzed are smaller than the
wild-type controls. This is an expected phenotype based on our
previous observations that showed Wnt5a(/) lungs to be
larger than the wild-type controls (Li et al., 2002a). Table 1
summarizes the lung/bodywet weight ratios of E18Wnt5a(/)
transgenic, and control lungs. As shown in Fig. 2, in early lung
development (E12), over-expression of Wnt5a results in
abnormalities in the pattern and the extent of epithelial
branching resulting in significantly reduced number of air-
ways. A consistent observation was that the left lung in the
transgenic embryos consisted of no more than 3 branched
structures in E12 embryos whereas nearly twice as many
branched airways were apparent in the wild type lungs (Fig.
2B compared to A). Again, the phenotype obtained in Wnt5a
transgenic lungs is the reverse of Wnt5a(/) lungs, whichTable 1
Lung/body wet weight ratio of E18 Wnt5a(/) embryos and Wnt5a
transgenic embryos
Control (%) Mutant (%) P value
Wnt5a(/) (E18) 4.13 4.79 <0.024
SpC–Wnt5a (E18) 3.95 2.47 <0.005exhibited over-expansion of distal airways (Li et al., 2002a),
and is therefore consistent with our previous observation.
Another abnormal phenotype of the E12 transgenic lungs is
the distal mesenchyme surrounding the clearly dilated epithe-
lial airways (Figs. 2B, D). This mesenchyme appears as excess
tissue at the distal tip of both the right and the left lungs
(arrowhead, Fig. 2B). In later stages of lung development, the
excess mesenchyme can be observed juxtaposed to dilated
airways (stars in Fig. 2H) surrounding the edge of the
transgenic lungs (Figs. 2F, H).
Morphology of Wnt5a transgenic lungs at later stages of
development is also shown in Figs. 2I to L. Consistent with the
reduced branching at early stages, E19 transgenic lungs have
reduced number of alveolar sacs (Fig. 2L) that are distinctly
dilated compared to the wild-type control lungs (Fig. 2K). In
addition, the inter-saccular walls in transgenic lungs appear
thinner than those in control lungs (Figs. 2K, L). However, the
excess mesenchyme, observed in earlier stages of lung
development was either entirely absent or only rarely observed
in E19 lungs. The phenotype of E19 transgenic lungs also
includes lobation abnormalities. The right lung consists of one
fused lobe (Fig. 2J) and in most cases, the accessory lobe is
entirely missing.
Because the excess mesenchyme present in E12 and E14
lungs was largely absent from E19 transgenic lungs, we
examined cellular proliferation and apoptosis by BrdU labeling
and TUNEL staining, respectively (Fig. 3). In E13 lungs, BrdU
incorporation was readily observed in both epithelial and
mesenchymal compartments of the lung. Quantification of the
number of BrdU-positive cells or TUNEL-positive cells on
multiple tissue sections showed no differences in the overall
frequency of proliferation or apoptosis in the epithelial cells
between the wild type and transgenic lungs (data not shown).
Little, if any, differences were discernible in the overall pattern
of BrdU staining in the mesenchyme, except in the areas of
Fig. 2. Gross morphology of E12 (panels A–D), E14 (panels E–H) and E19 (panels I–L) wild-type control (panels A, C, E, G, I, K) and Wnt5a transgenic lungs
(panels B, D, F, H, J, L). The numbers in panels A and B indicate the number of terminal lung buds in the left lobe. Arrowheads indicate the excess mesenchyme
adjacent to the distal airway. The stars in panel H indicate dilation of distal tips of E14 Wnt5a transgenic lung airways. The numbers in panels I and J indicate the
number of lobes of E19 control and Wnt5a transgenic lungs. The stars in panels K and L indicate alveolar sacs in E19 Wnt5a transgenic lung (panel L) that are
dilated. e and m represent epithelium and mesenchyme, respectively. Scale bar, 200 Am (A, B); 70 Am (C, D); 2.0 mm (I, J); 50 Am (K, L).
C. Li et al. / Developmental Biology 287 (2005) 86–97 89excess mesenchyme, in which proliferation appeared to be
virtually absent (dashed box, Fig. 3B). Conversely, the excess
mesenchyme in the transgenic lungs was the only significant
site of apoptosis as assayed by TUNEL (dashed box, Fig. 3D).Fig. 3. Proliferation and apoptosis in wild type and Wnt5a transgenic lungs
determined by BrdU and TUNEL labeling, respectively. Proliferation in E13
wild type control (A) and Wnt5a transgenic (B) lungs was determined by BrdU
labeling. The proliferating cells were visualized by CY3 (red) labeled
secondary antibodies. Apoptosis in E13 wild type control (C) and Wnt5a
transgenic (D) lungs was determined by TUNEL labeling. The apoptotic cells
were visualized by FITZ (green) labeled DNA strand breaks. Tissues were
counter-stained with DAPI (blue) for nuclei. The dashed boxes in panels B and
D indicate areas of excess mesenchyme in Wnt5a transgenic lung.Expression of key mediators of lung morphogenesis in Wnt5a
transgenic lungs
To understand the underlying mechanisms by which over-
expressed Wnt5a affects lung branching morphogenesis, we
examined the expression of a number of key mediators of
normal embryonic lung development. These included the
signaling pathways controlled by SHH, BMP4 and FGF10.
As shown in Fig. 4, Shh mRNA is decreased by 36% and
Fgf10 is increased by nearly 165% in E13 Wnt5a transgenic
lungs when compared to the wild type levels. No difference in
expression of Bmp4 was detected (Fig. 4).Fig. 4. Relative abundance of Shh, Fgf10 and Bmp4 transcripts in E13 Wnt5a
transgenic and wild type control lungs was determined by Realtime PCR and
normalized by beta-actin. The ratios of the relative mRNA abundance in
transgenic over control lungs were then calculated and shown as the black bars.
White bars represent the relative mRNA abundance in control lungs and were
arbitrarily set as 1. Each result is the mean of at least 5 independent
experiments. ***P < 0.003.
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Shh, Bmp4 and Fgf10 by whole-mount in situ hybridization.
No differences in the distribution of Shh mRNAwere detected
between the transgenic lungs and wild type control lungs (Figs.
5A–D). However, both expression level and spatial distribu-
tion of SHH receptor Ptc were profoundly reduced in the
transgenic lungs (arrow, Fig. 5H), suggesting that Wnt5a may
negatively regulate SHH signaling. Since transcription of Ptc is
controlled by the SHH mediator Gli, which itself is transcrip-
tionally activated by SHH signaling, we also determined the
expression of Gli by whole-mount in situ hybridization (Figs.
5I to L). Both expression level and spatial distribution of Gli
were reduced but overlapping with Ptc in the transgenic lungs
(arrow, Fig. 5L). Interestingly, changes in the spatial distribu-
tion of Ptc and Fgf10 mRNA appeared to be mutually
reciprocal. Consistent with the Realtime PCR results, expres-
sion of Fgf10 is greatly increased and broadly distributed in theFig. 5. Expression of Shh, Ptc, Gli, Fgf10 and Bmp4 in control andWnt5a transgeni
E12 control (A, C) and transgenic (B, D) lungs. Arrows indicate Shh transcripts dete
transgenic (F, H) lungs. Arrow in panel H indicates reduced expression and range of P
expression of Gli in E13 control (I, K) and transgenic (J, L) lungs. Arrow in panel L
distal airways in transgenic lung. Panels M–P, expression of Fgf10 in E13 contr
expression and range of Fgf10 in the mesenchyme around the distal airway in tra
transgenic (R, T) lungs. Arrow in panel T indicates area in which expression of Bmp4
Scale bar, 400 Am (A, B, E, F, I, J, M, N, Q, R); 133 Am (C, D, G, H, K, L, O, Pmesenchyme along the edges of transgenic lung lobes (Figs.
5N, P) precisely where repression of Ptc domain is observed.
The spatial pattern of Bmp4 expression also appeared to
have been altered in transgenic lungs. In wild type lungs, Bmp4
is highly localized to the growing tip of each distal branching
airway (Figs. 5Q, S). In contrast, the expression pattern of
Bmp4 in the transgenic lungs is broadened and spans across the
entire distal tip of the airway epithelium (arrow, Fig. 5T). This
pattern corresponds to the more broadly distributed Fgf10
mRNA in the transgenic lungs (arrow, Fig. 5P).
It has been shown that SHH represses Fgf10 at the
transcriptional level. It may therefore be rational to conclude
that the observed increase in Fgf10 gene expression in the
transgenic lungs, also described in Fig. 4, is mediated through
changes in SHH in response to over-expression of Wnt5a.
Alternatively, the mesenchyme in Wnt5a transgenic lungs may
have lost its capacity to respond to SHH. To examine thesec lungs by whole-mount in situ hybridization. Panels A–D, expression of Shh in
cted at distal airways. Panels E–F, expression of Ptc in E13 control (E, G) and
tc in the mesenchyme around the distal airways in transgenic lung. Panels I–L,
indicates reduced expression and range of Gli in the mesenchyme around the
ol (M, O) and transgenic (N, P) lungs. Arrow in panel P indicates increased
nsgenic lung. Panels Q–T, expression of Bmp4 in E12 wild type (Q, S) and
spans across the entire distal tip of the airway epithelium in the transgenic lung.
, S, T).
Fig. 6. Exogenous recombinant SHH inhibits Fgf10 gene expression in Wnt5a
transgenic lung explants. E12 transgenic lungs were explanted in vitro and
treated with recombinant SHH (B, D) or BSA (A, C) as control for 20 h as
described in Materials and methods. Subsequently, in situ hybridization was
used to localize Fgf10 or Ptc mRNA. Fgf10 in transgenic lungs treated with
SHH was reduced significantly (Panel B) compared to control (Panel A). In
contrast, transgenic lungs treated with SHH showed increased expression of Ptc
(Panel D) compared to control (Panel C). Scale bar, 0.2 mm.
Fig. 7. Overexpression of Wnt5a decreases Shh promoter activity. A549 cells
were co-transfected with Shh promoter-luciferase reporter construct (Shh) and
CMV-Wnt5a expression plasmids. The pRC/CMV that contains CMV promoter
alone was used as control (CMV). Another control plasmid, a TK-luciferase
reporter construct (TK) was also co-transfected separately with either CMV-
Wnt5a or CMV. White bars represent co-transfection with the control vector,
CMV and black bars represent co-transfection with CMV-Wnt5a. The Shh
promoter activity was decreased and the activity of TK promoter was slightly
increased by over-expression of Wnt5a. Data represent 6 independent
experiments. P value, 0.0004.
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transgenic lungs to recombinant SHH (R&D systems). Expo-
sure to recombinant SHH for 20 h significantly decreased
Fgf10 expression as detectable by in situ hybridization (Fig.
6B) compared to the non-treated lungs as shown in Fig 6A.
Importantly, the increased mRNA level for Ptc (Fig. 6D), used
as a positive control, clearly indicates that the recombinant
SHH used in this study is biologically active.
To further determine whether over-expression of Wnt5a
decreases Shh, we cotransfected lung carcinoma A549 cells
with Shh promoter-luciferase reporter construct and Wnt5a
expression construct. WNT signaling has been shown to be
functional in A549 cells (You et al., 2004). As shown in Fig 7,
over-expression of Wnt5a leads to 30% decrease in Shh
promoter activity, but no decrease in the activity of the
thymidine kinase (TK) promoter. Therefore, Shh promoter
activity is specifically repressed by Wnt5a.
Wnt5a over-expression disrupts the response of the lung
epithelium to FGF10
As shown in Fig. 3, epithelial over-expression of Wnt5a
causes reduced branching and an abnormally dilated airway
phenotype in transgenic lungs. The latter phenotype occurs in
the face of increased Fgf10 expression in the mesenchyme
(Fig. 5P). Thus, one important question relates to whether the
reduced branching and dilation of airways are an intrinsic
property of the transgenic epithelium, and therefore a direct
consequence of Wnt5a over-expression acting in an autocrine
fashion on the epithelium. To address this question, we utilized
an in vitro model of mesenchyme-free epithelial explant cultureto compare the response of transgenic and wild type airways
(epithelium) to FGF signaling. Mesenchyme-free airways,
isolated from multiple Wnt5a transgenic and wild type lungs,
were examined with respect to their ability to respond to
exogenously added recombinant FGF10 and FGF7, two
mesenchymally derived key molecules necessary for morpho-
genesis of the lung epithelium (Bellusci et al., 1997b). As
shown in Fig. 8, both the wild-type and the transgenic
mesenchyme-free epithelial airways responded to FGF10 and
underwent branching around 48 h after culturing (Figs. 8C, D).
The frequency of primary branches formed on the transgenic
versus the wild type airways appeared to be the same.
However, similar to the phenotype of the airway structures
observed in vivo (Fig. 2), the branching tips of transgenic
airways were significantly dilated with internal diameters
ranging from 18 to 60 Am (Average of 36 Am, standard error
of 2 Am of a total of 39 airway tips measured, Fig. 8J). In
contrast, no dilation was observed in the wild-type control
explant buds, which showed internal diameters, no larger than
8 Am (Fig. 8I). This finding supports the conclusion that over-
expression of Wnt5a disrupts the response of the transgenic
epithelium to FGF10, an intrinsic property of the transgenic
epithelium. No significant differences were observed in the
response of the transgenic and control epithelial airways to
FGF7.
As an additional approach to investigate the role of Wnt5a
in epithelial branching, we examined in time and space, the
response of Wnt5a transgenic epithelium derived from indi-
vidual lungs to a directional FGF10 signaling provided by
FGF10-saturated beads (Fig. 9). As compared to the previous
setting, described above, in which the lung epithelial explants
are exposed to a uniform concentration of FGF10 in Matrigel,
the current study utilized recombinant FGF10-saturated beads
that establish a gradient of FGF10 concentration by passive
diffusion. The result of these studies clearly show that within
48 h of culturing, Wnt5a transgenic explants failed to respond
Fig. 8. Response of mesenchyme-free epithelial explants from wild type and Wnt5a transgenic lungs to recombinant FGF. Distal epithelial explants of E12 wild type
(A, C, E, G) and transgenic (B, D, F, H) lungs were isolated and cultured in Matrigel, supplemented with 400 ng/ml recombinant FGF10 (A–D), or 100 ng/ml FGF7
(E–H) for 48 h. Panels A, B, E and F show the epithelial explants before culturing. Panels C, D, G and H show the epithelial explants after 48 h of culturing. Panels I
and J show higher magnification of buds from panels C and D, respectively. Arrows indicate the dilated distal ends of buds from transgenic explants. Data represent
at least 14 cultured control or transgenic explants for FGF10 and 9 for FGF7 from 3 pairs of control and transgenic lungs from each of two independent litters. Scale
bar, 200 Am (A–H); 45 Am (I, J).
C. Li et al. / Developmental Biology 287 (2005) 86–9792to directional FGF10 signaling when they were placed 215 Am
to 260 Am away from the beads. In contrast, there was clear
evidence of chemotaxis in the direction of the FGF10 beadsFig. 9. Response of mesenchyme-free epithelial explants from wild type and Wn
explants of E12 wild type (A) and transgenic (D, H) lungs were isolated and cultured
initial distance of explant and bead remains between 215 Am and 260 Am, three out
explants responded. When the transgenic explant was very close to the FGF10-satueven within the first 20 h of culturing by wild-type lung
epithelial explants placed at the same distance from the
signaling source. Since diffusion, and therefore concentrationt5a transgenic lungs to recombinant FGF10-saturated beads. Distal epithelial
in the neighborhood of FGF10-saturated beads in Matrigel for 48 h. When the
of four wild-type explants responded to FGF10 and none of the three transgenic
rated bead (100 Am, H), it migrated toward the bead. Scale bar, 160 Am.
C. Li et al. / Developmental Biology 287 (2005) 86–97 93or intensity of FGF10 signaling is inversely proportional to the
distance from the beads, it appears that chemotaxis of
transgenic explants requires a higher FGF10 concentration.
This possibility was verified by placement of transgenic
explants at 100 Am from larger FGF10 beads, exposing the
explants to a higher gradient of FGF10. As expected, the higher
FGF10 levels resulted in chemotaxis of transgenic explants
(Figs. 9H to K).
Discussion
The results of this study demonstrate that lung epithelial-
specific over-expression of Wnt5a in transgenic mice results in
non-lethal abnormalities, both in the epithelium and the
mesenchyme of the developing lung. Transgenic lungs were
consistently smaller than wild type controls with lobation
abnormalities. Paracrine effects of Wnt5a over-expression
included abnormalities in the mesenchyme exemplified by
increased expression of the key chemotactic growth factor,
FGF10. Despite increased FGF10, Wnt5a over-expression
inhibited epithelial branching, suggesting that Wnt5a is a key
autocrine/paracrine signaling pathway that is necessary for the
normal response of the lung epithelium to chemotactic
signaling by FGF10. In addition, changes in the expression
of key mediators of lung development, including Shh, Ptc and
Bmp4 were observed in transgenic lungs. This study also
demonstrates that distribution of Ptc and Fgf10 are reciprocally
and dynamically related, with implications regarding the
overall mechanisms of branching morphogenesis.
In a previous study, we showed that targeted disruption of
Wnt5a resulted in increased overall lung size, increased cell
proliferation and enhanced branching (Li et al., 2002a). Thus,
the findings of smaller size and reduced branching in the
Wnt5a transgenic lungs are consistent with previous observa-
tions. To address the underlying mechanisms for the latter
phenotypes, we examined cellular proliferation and apoptosis.
With the exception of specific areas of the transgenic
mesenchyme (please see below), BrdU and TUNEL analyses
showed no significant differences between the transgenic and
wild type lungs (Figs. 3A, B). This observation is consistent
with the report of Lu et al. (2005) founding little evidence for
alterations in cellular proliferation during the branching
response of lung epithelium to FGF10. Wnt5a is known to
alter processes such as cell shape and cellular movement, both
of which appear to be involved in branching morphogenesis
(Lu et al., 2005). For example, during Xenopus gastrulation
Wnt5a activates JNK to regulate convergent extension move-
ments (Yamanaka et al., 2002). Kuhl et al. (2001) reported that
convergent extension movement can be antagonistically
regulated by the WNT/beta catenin and WNT/Ca2+ signaling.
Over-expression of Wnt5a in melanoma cells leads to increased
cell adhesion and invasion (Weeraratna et al., 2002).
During lung branching morphogenesis, the factors that
control epithelial cell proliferation and movement include
Fgf10 and Bmp4. Profound inhibition of lung branching
morphogenesis occurs in mice lacking Fgf10 (Min et al.,
1998). Over-expression or altered spatial distribution of Bmp4also reduces branching morphogenesis (Bellusci et al., 1996).
Cross-talk between the mesenchyme and the epithelium
regulates spatial, temporal and level of gene expression for
Fgf10, Bmp4 and many other morphoregulatory molecules. In
the wild type lung, precisely localized expression of Fgf10 and
Bmp4 is key to epithelial dichotomous branching behavior.
Highly localized expression of Fgf10 in the mesenchyme
adjacent to the growing tip of the nascent airways promotes
epithelial morphogenesis in the outward direction. Concomi-
tantly, FGF10 signaling promotes a steady increase in the level
of Bmp4 transcription in epithelial cells forming the tip of the
advancing airway (Lebeche et al., 1999; Weaver et al., 2000;
Hyatt et al., 2004). In vitro results suggest that Bmp4 is
inhibitory to epithelial proliferation and cell movement
(Weaver et al., 2000). Thus, largely based on these findings,
a model has been proposed in which, high-level threshold
concentrations of Bmp4, in response to FGF10 signaling
ultimately inhibit epithelial cell proliferation/movement and
arrest outward movement of the advancing airways. In this
model, Fgf10 expression gradually decreases at the tip but is
up-regulated laterally by an as yet unknown mechanism,
allowing for initiation of lateral budding and hence dichoto-
mous branching of the nascent airway. Fgf10 mRNA was both
increased and distributed in a significantly expanded mesen-
chymal domain in the transgenic lungs (arrow, Fig. 5P),
compared to its highly localized pattern of expression in the
wild type (arrows, Fig. 5O). The above model (Weaver et al.,
2000) predicts that this pattern of Fgf10 expression in the
transgenic mesenchyme would result in (1) expanded, abnor-
mal pattern of Bmp4 expression in the adjacent epithelium, (2)
disrupted branching pattern and (3) increased branching in
transgenic lungs. In Wnt5a transgenic lung, we found high
level Bmp4 expression in the lateral epithelium that persisted,
albeit at lower levels across the advancing face of the distal
epithelium. Also, the pattern of airway branching was indeed
abnormal (Fig. 2B). Most importantly, however, in contradic-
tion to the model’s prediction, we observed decreased branch-
ing in Wnt5a transgenic lungs, associated with distal airway
dilation.
Interestingly, several mutations that cause reduced branch-
ing are also accompanied by airway dilation. For example,
mice lacking elastin, Eln(/), show arrested terminal airway
branching as well as dilated distal air sacs (Wendel et al.,
2000). A very severe case, gene targeting of the Nkx2.1, a
transcription factor expressed in lung epithelium, results in
two dilated epithelial sacs (Minoo et al., 1999). Similarly,
Shh(/) lungs consist of a rudimentary organ with a few
dilated airways (Pepicelli et al., 1998). To determine if
reduced branching and dilated airway ends are intrinsic
properties of the Wnt5a transgenic epithelium, we used two
in vitro models of mesenchyme-free epithelial growth and
branching in explant cultures. First, isolated epithelial airways
from E12 embryonic lungs were cultured in Matrigel in
presence or absence of a given concentration of recombinant
human FGF10. In the absence of FGF10, neither the wild
type nor the Wnt5a transgenic lung isolated airways showed
signs of branching (Fig. 8). Addition of recombinant FGF10
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mesenchyme-free airways. In contrast, the response of the
transgenic epithelium to recombinant FGF10 was clearly
abnormal and resulted in the formation of dilated ends, nearly
identical to those observed in embryonic Wnt5a transgenic
lungs. Although the isolated transgenic epithelium branched,
the airway morphology was consistently different compared
to the wild type controls. In explanted lungs, FGF7 has been
previously shown to result in epithelial dilation (Bellusci et
al., 1997b). However, whole mount in situ hybridization for
Fgf7 using E13 lungs showed low level expression of Fgf7
which was not different in Wnt5a transgenic lungs, compared
to wild type (data not shown). Therefore, we conclude that
the dilated ends reflect an intrinsic property of the transgenic
epithelium, presumably related to over-expression of Wnt5a.
In a second set of experiments, the mesenchyme-free lung
epithelial explant culture model was used to examine the
reduced branching phenotype observed in Wnt5a transgenic
lungs. In contrast to the first approach (above), we use a
directional, gradient source of recombinant FGF10 and time-
lapse photography to examine the chemotactic behavior of wild
type and transgenic epithelial explants in space and time
dimensions. These experiments were repeated three times using
independently derived transgenic and wild type lung explants.
The results unanimously showed a clear difference in the
response of the Wnt5a transgenic explants to FGF10 signaling,
when compared to wild type (Fig. 9). Thus, epithelial over-
expression of Wnt5a appears to interfere with an as yet
unknown mechanism that is required for reception, interpreta-
tion and/or response to FGF10 signaling. We therefore, propose
that over-expression of Wnt5a decreases the chemotactic
ability of the epithelium to undergo outgrowth and extension
in response to FGF10 signaling, which in turn may explain the
observed reduced airway branching in transgenic lung. A
number of mediators in the FGF signal transduction pathway
have been identified (for review, see Bottcher and Niehrs,
2005). For example, FGF-Receptor 2 (FGFR2) is essential for
activation of both FGF10 and FGF7 pathways (Wilkie et al.,
2002). Preliminary results show no differences in the level of
FgfR2 gene expression between the wild type and Wnt5a
transgenic lungs (Li et al., unpublished). We are currently
examining phosphorylation of extra-cellular signal-related
kinase 1 and 2 (Erk1/2), the serine/threonine kinases that have
been shown to mediate FGF10 signaling, in the wild type and
transgenic lungs. Thus, at present, the molecular causes
underlying the alterations in FGF10 response in Wnt5a
transgenic lungs remains unknown.
Realtime PCR analysis revealed decreased Shh mRNA in
Wnt5a transgenic lungs (Fig. 4). Although in situ results
showed that distribution of Shh does not change, the range of
SHH signaling represented by the domain of Ptc expression
was reduced significantly in Wnt5a transgenic, compared to
wild type lungs. Similar to our findings in the current study,
Fgf10 domain of expression was expanded in the Shh(/)
lung mesenchyme (Pepicelli et al., 1998). Conversely, in vitro
treatment of lung mesenchymal cells with recombinant SHH
decreased Fgf10 gene expression (Lebeche et al., 1999). Thesedata clearly indicate that Fgf10 gene expression in the lung
mesenchyme can be modulated by SHH signaling. Consistent
with this conclusion, Fgf10 was increased and its spatial
distribution expanded in Wnt5a transgenic lungs (Fig. 5P).
Furthermore, increased Fgf10 expression was repressed by
treatment of transgenic lung explants with recombinant SHH
(Fig. 6). Thus, we propose that decreased SHH signal may
underlie the increased level of Fgf10 mRNA and its expanded
distribution in Wnt5a transgenic lungs.
Alteration in SHH signaling has also been associated with
morphological abnormalities in lung development. Transgenic
over-expression of Shh in the distal lung epithelium was shown
to increase mesenchymal cell proliferation (Bellusci et al.,
1997a). One notable and consistent feature of the Wnt5a
transgenic lungs is the abnormal phenotype of the distal
mesenchyme. As early as E12, the abnormal phenotype can be
seen as what appears to be excess mesenchyme, localized to the
distal tip of the dilated airways (Fig. 2D). This abnormal
phenotype was not present in lungs from later stages of
embryonic development. Examination by BrdU labeling
showed reduced cell proliferation in areas of excess mesen-
chyme. In contrast, apoptosis, as assayed by TUNEL staining,
was clearly localized and increased in these areas (Fig. 3).
The latter observation may represent the mechanism by
which the excess mesenchyme is resolved in lungs from
later stages of development (i.e., E15–E19). Absence of
increased proliferation in the abnormal mesenchyme likely
suggests that what appears initially as overgrown tissue may
simply represent mesenchyme into which the transgenic
epithelium has failed to branch, presumably due to Wnt5a
over-expression. Activation of apoptosis in these mesenchy-
mal domains suggests the presence of an epithelial–
mesenchymal cross-talk mechanism, possibly related to
SHH signaling by which proliferation/apoptosis of mesen-
chyme is linked to epithelial cell morphogenesis (i.e.,
branching behavior). Although highly speculative, this
contention is supported not only by the findings in this
study of reduced Shh mRNA (Fig. 4) and contracted
domains of Ptc mRNA in the transgenic lungs (Fig. 5H),
suggesting reduced SHH signaling, but also by the results of
other experimental studies (Bellusci et al., 1997a).
An integrated model of Wnt5a interactions with SHH and
FGF10 signaling pathways
Based on results of the current study and the model by
Weaver et al. (2000), we propose that during early lung
development, Wnt5a represses SHH signaling (interaction ,
Fig. 10). This is supported by two independent, but comple-
mentary observations; decreased Shh mRNA in Wnt5a
transgenic lungs (Fig. 4), and repression of Shh promoter in
A549 cells co-transfected with a Wnt5a expression construct.
In addition, decreased mRNA levels and altered distribution of
Ptc and Gli (Fig. 5) observed in Wnt5a transgenic lungs
provide further support that Shh signaling is indeed reduced by
over-expression of Wnt5a. Since SHH signaling negatively
regulates Fgf10 expression in the mesenchyme (interaction `,
Fig. 10. A simplistic schematic model of Wnt5a interactions with SHH and
FGF10 signaling during lung development. Models of interactions between
Shh, Fgf10 and Bmp4 were proposed previously by Weaver et al. (2000).
Current study suggests that Wnt5a negatively regulates SHH signaling which
leads to abnormal Fgf10 expression (interaction  and `). Also, the response
of epithelial cells to FGF10 is proposed to be controlled by Wnt5a, suggesting
Wnt5a may interact with FGF10 signaling in the epithelial cells (interaction ´).
Whether Fgf10 is directly regulated by Wnt5a remains to be determined.
C. Li et al. / Developmental Biology 287 (2005) 86–97 95Fig. 10), over-expression of Wnt5a leads to increased Fgf10
mRNA level and distribution (Fig. 5P).
FGF10 acts as a chemotactic and proliferation factor for the
distal epithelium and induces the expression of Bmp4.
However the response of Wnt5a transgenic epithelium to
FGF10 is disrupted by the presence of increased Wnt5a. The
latter conclusion is supported by several observations. First,
mesenchyme-free epithelial explants from transgenic lungs
form dilated distal tips when treated with recombinant FGF10
(Fig. 8). Secondly, airway branching of transgenic lungs is
reduced in vivo even though Fgf10 expression is dramatically
increased (Figs. 5M to P). Thirdly, chemotaxis of transgenic
lung epithelial explants towards a directional FGF10 source
was inhibited by over-expression of Wnt5a. This suggests that
Wnt5a may interact with FGF10 signaling pathway to control
the behavior of the epithelium (interaction ´, Fig. 10). The
precise mechanism by which the latter disruption occurs
remains to be investigated.
Materials and methods
Generation of transgenic mice
A 2.5-kb EcoR1 fragment of Wnt5a cDNAwas cloned into the EcoR1 site
of the vector pSpc/SV40 (Zhou et al., 1996). In order not to disturb the structure
of WNT5A protein, we chose to not Tag the coding region of Wnt5a. The
Not1–Nde1 DNA fragment that contains a 3.7-kb SpC promoter, 2.5-kbWnt5a
cDNA, the SV40 t-intron and the SV40 polyA signal was released from the
plasmid and used for transgenic injection. Four pseudo-pregnant mice each
implanted with approximately 20 to 22 injected fertilized eggs were generated.
Neonates born to each surrogate mother were genotyped by Southern blot and
monitored closely at birth for signs of pulmonary distress. All seven founders
were viable. The founders were crossed to wild-type C57BL/6 to generate F1
transgenic males. Wild-type C57BL/6 females were then crossed with the F1
transgenic males and used to study lung morphogenesis in F2 transgenic
females and males. Expression of theWnt5a transgene was studied by Northern
blot analysis with a probe generated from a 0.4-kb SV40 t-intron-polyA
sequence.
Realtime polymerase chain reaction (PCR)
The quantification of the selected genes by Realtime PCR was performed
using a LightCycler (Roche, Mannheim, Germany). The optimal PCR reactions
for all investigated genes were established using the LightCycler Fast Start
DNA Master SYBR Green I Kit (Roche), according to the manufacturer’s
instructions; annealing temperatures and MgCl2 concentrations were optimizedto create a one-peak melting curve. Additionally, the PCR reactions were
recovered after each PCR analysis and PCR products were checked by agarose
gel electrophoresis for a single band of the expected size. The running protocol
was programmed on the LightCycler software, version 3.5. Each reaction had a
total volume of 20 Al including 2 Al of cDNA and 18 Al of a reaction mixture.
The program consisted of the following four steps. (i) denaturation program,
94-C, 5 min; (ii) amplification and quantification program, 10 s at 95-C, 5 s at
60-C and 15 s at 72-C; (iii) melting curve program, the reaction temperature
was rapidly increased to 95-C, then decreased to 60-C for 15 s, and finally
slowly increased to 98-C at a rate of 0.1-C per second, with continuous
fluorescence monitoring; (iv) cooling program down to 40-C.
A relative quantification analysis on a single channel experiment was carried
out. The analysis uses the sample’s crossing point, the efficiency of the reaction
(specified as efficiency value of 2), the number of cycles completed, and other
values to compare the samples and generate the ratios. Two ratios were
compared: the ratio of a target gene to a reference gene (h-actin) in samples of
transgenic lungs, to the ratio of the same two genes in samples of control lungs
served as ‘‘Calibrator’’. The results are expressed as a normalized ratio.
Sequences of the primers of the genes are as follows. beta-actin: 5V-
GAGCTGCCTGACGGCCAGGT-3V (forward), 5V-TACTCCTGCTTGCT-
GATCCA-3V (backward). Shh: 5V-GTGGCCGAGAAGACCCTAG-3V (forward),
5V-AGACGTGGTGATGTCCACTG-3V (backward). Fgf10 : 5V-CACA-
TTGTGCCTCAGCCTTTCC-3V (forward), 5V-CCTGCCATTGTGCTGC-
CAGTTAA-3V (backward). Bmp4: 5V-CGCTCAGGGCAGAGCCATGA-3V (for-
ward), 5V-TGGAAGCCCTGTTCCCAGTC-3V (backward).
Cell culture and transient transfection assay
Human pulmonary epithelial cell lines A549 (ATCC) was maintained in
F-12K Nutrient medium (GIBCO-BRL, Gaithersburg, MD), containing 10%
fetal bovine serum and 1% penicillin-streptomycin. All plasmids used in
transfection studies were purified on QIAGEN columns (Qiagen). Transient
transfection of A549 cells was performed with SuperFect (Qiagen) as
described previously (Li et al., 2002b). The Shh promoter-luciferase reporter
construct (Shh) was made by cloning a 1.9-kb human Shh promoter
sequence (nucleotide 3347 to 1548 of NT 007741) to XmaI/BglII sites of
pGL2 basic (Promega). The TK-luciferase reporter plasmid was described
previously (Li et al., 2002b) and the pSV-beta-gal was purchased from
Promega. The Wnt5a expression plasmids (CMV-Wnt5a) was constructed by
inserting a 1.54-kb mouse Wnt5a cDNA containing the entire coding region
into the HindIII/XbaI sites of pRC/CMV (Invitrogen). Luciferase activity
was measured as described (Li et al., 2002b) and normalized by beta-
galactosidase activity for each transfection.
Lung culture and lung epithelial explant culture
Lung culture was performed as described (Xiao et al., 2003). In brief,
whole embryonic lungs were dissected out at gestational stage E12. In each
Grobstein Falcon dish, four to six pieces of lung lobes were placed on
filters (Millipore, Bedford, MA) that were placed on top of a stainless steel
grid. The filters were in close contact with BGJb (GIBCO) growth medium
supplemented with penicillin (100 U/ml) and streptomycin (100 Ag/ml),
with 3 Ag/ml recombinant mouse SHH peptide, SHH-N (R&D systems) or
same amount of BSA (as control). The lungs were incubated under optimal
humidity and 95% air/5% CO2 for 20 h, and then fixed in 4% PFA,
dehydrated to 70% ethanol before whole-mount in situ assay.
For lung explant culture, distal lung tips were isolated as described
previously (Bellusci et al., 1997b). Lungs from transgenic or wild-type
control embryos were dissected at E12.5 and treated with Dispase (50U/ml,
BD Biosciences) at 4-C for 20 min. Epithelial buds of distal lung tips were
then isolated by removing mesenchyme with tungsten needles and
embedded into growth factor reduced Matrigel (Fisher Scientific) diluted
1:1 in culture medium (50% DMEM:50% Ham’s F12, 0.05 U/ml penicillin,
0.05 mg/ml streptomycin). After polymerization of the Matrigel at 37-C,
explants were covered with culture medium with or without FGFs and
cultured at 37-C at 5% CO2 for up to 2 days. FGF10-saturated beads were
prepared with acrylic beads with immobilized heparin (Sigma). Beads were
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and then soaked in 50 ng/Al recombinant human FGF10 at 37-C for 1 h.
The beads were then washed in DMEM medium for 1 h at 37-C before
use. The explant cultures were photographed at different time points and the
distances between explants and the beads were measured.
RNA extraction and Northern blot
Total RNA was isolated from lungs of embryos or neonates at various
developmental stages using Trizol (GIBCO). Ten or twenty microgram of the
total RNA was electrophoresed in 1% RNA formaldehyde agarose gel and
northern blotted. Blots were hybridized with probes derived from a 0.4-kb SacI
fragment of SV40-t intron-polyA sequence and then autoradiographed.
In situ hybridization
Anti-sense RNA probes were prepared with Digoxigenin as described
(Li et al., 2002a). E12 to E13 mouse embryonic lungs were fixed with 4%
paraformaldehyde (PFA) in Calcium/Magnesium-free DEPC-PBS at 4-C,
The tissues were then washed, treated with 15 Ag/ml proteinase K for 5
min, re-fixed in 0.2% glutaraldehyde/4% PFA for 20 min, and then
incubated with hybridization mix including the anti-sense DIG-labeled RNA
probe at 68-C overnight. Anti-DIG-AP conjugate (Roche) was used to
detect the RNA probe, and the color was developed with BM purple
(Roche). The 0.64-kb Shh cDNA, was kindly provided by Dr. Andrew P.
McMahon (Harvard University). The probe for Ptc was a 0.7-kb fragment
from the Ptc cDNA (Kindly provided by Dr. Matthew P. Scott, Stanford).
The probe for Bmp4 was a 1.5-kb Bmp4 cDNA (Kindly provided by Dr.
Brigid L. M. Hogan, Duke University). The probe for Fgf10 was a 0.6-kb
PCR product of the Fgf10 coding region. The probe for Gli was a 0.74-kb
PCR amplified Gli cDNA.
Immunohistochemistry
For immunohistochemistry, 5-Am tissue sections were prepared. Subse-
quent to deparaffinization, the sections were hydrated, heated in 10 mM
citrate buffer (pH 6.0) and treated with 1% H2O2 in methanol for 10 min
and blocked with 10% of normal serum. The sections were then incubated
with primary antibodies at 4-C overnight. Biotinylated secondary antibody
and streptavidin–peroxidase conjugate (Vector Laboratories, Inc.) were used
to detect the bound antibodies. The sections were developed with
diaminobenzidine. WNT5A primary antibody was purchased from R and
D Systems.
Proliferation assay
Pregnant female mice were injected intraperitoneally with bromodeox-
yuridine (BrdU) reagent at 100 Al per 10 g body weight. Ten minutes after
injection, embryonic lungs were dissected out, fixed, dehydrated and
paraffin embedded. The sections were then re-hydrated and treated with
monoclonal anti-BrdU (Clone BU-1, RPN 202) as recommended by the
manufacturer (Amersham Biosciences). CY3-labeled secondary antibodies
were used. Vectashield with DAPI was used as a mounting medium. The
sections were then photomicrographed. The labeled cells as well as the
total number of cells of the lungs per section, photomicrographed at 20,
were counted. At least nine fields of distal lung were counted and at least
80 cells were counted per field. The percent of labeled cells was
calculated.
Apoptosis assay
Lungs were fixed in 4% paraformaldehyde for 20 min, washed in PBS,
dehydrated and paraffin embedded. The ‘‘In situ cell death detection kit,
fluorescein’’ for detection of apoptosis at single cell level, based on labeling of
DNA strand breaks (TUNEL technology), from Roche Applied Science was
used per standard instructions. All slides were mounted with DAPI containing
Vectashield and photomicrographs were taken.Acknowledgments
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